OpenAlex
PricingAboutJobs
Log inGet started
Work

Renoprotective effects of sodium-glucose cotransporter-2 inhibitors

HTML

Year: 2018
Type: review
Source: Kidney International
DOI: 10.1016/j.kint.2017.12.027
Authors: Hiddo J.L. Heerspink, Mikhail Kosiborod, Silvio E. Inzucchi, David Z.I. Cherney
Institutions: University Medical Center Groningen, University of Groningen, University of Missouri–Kansas City, Yale University, University of Toronto, Toronto General Hospital
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: SGLT2 inhibitors, renal protection, type 2 diabetes, diabetic nephropathy, cardiovascular risk reduction, empagliflozin, canagliflozin, albuminuria, renal hyperfiltration, major adverse cardiovascular events, heart failure hospitalization, chronic kidney disease, EMPA-REG OUTCOME trial, CANVAS trial
SDG: Good health and well-being

Open Access status: bronze

Funder: Canadian Institutes of Health Research
OpenAlex ID: W2800723402
FWCI: 5.757
Cites: 142
Cited by: 421
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security